Skip to content

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Biodegradable ROS-Responsive TPCD Nanoparticles Mitigate Cisplatin-Induced Acute Kidney Injury via Synergistic Antioxidant and Immunomodulatory Actions

TPCD NPs demonstrate renoprotective effects in cisplatin-induced AKI, likely via combined antioxidant, anti-apoptotic, and immunomodulatory actions, and long-term safety and efficacy in other AKI models remain to be established.

Qin Wang, Wen Zhen, Zhou-Ke Tan et al. · 0 citations
Open access Sep 2026

A palmitoylation-associated three-gene signature predicts prognosis, immune features, and drug sensitivity in gastric cancer: functional validation of CTHRC1

The SERPINE1/CTHRC1/EGR1 signature provides prognostic and immune-stromal information in GC, and the experiments support a tumor-promoting role for CTHRC1, which defines a palmitoylation-associated transcriptional framework but do not establish a palmitoylation-dependent mechanism.

Hong-Mei Sheng, Xue-Jun Li, Chen Zhang et al. · 0 citations
Open access Sep 2026

Palmitoylation-related lncRNAs link molecular signaling, immune remodeling, and tumor progression in glioma: prognostic modeling and functional validation of LYRM4-AS1

This study identifies a palmitoylation-related lncRNA signature that integrates molecular signaling, immune remodeling, and prognosis in glioma and indicates LYRM4-AS1 acts as a functional driver of glioma progression and may represent a candidate biomarker and therapeutic target at the crossroads of neural tumorigenes...

Juan Xu, Chen Zhang, L. Pu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.